Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by increased mortality associated with cardiometabolic disorders including dyslipidaemia, insulin resistance, and cachectic obesity. Tumour necrosis factor inhibitors and interleukin 6 receptor blocker licensed for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cachexia Sarcopenia Muscle
Main Authors: Tournadre, Anne, Pereira, Bruno, Dutheil, Fréderic, Giraud, Charlotte, Courteix, Daniel, Sapin, Vincent, Frayssac, Thomas, Mathieu, Sylvain, Malochet‐Guinamand, Sandrine, Soubrier, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566648/
https://ncbi.nlm.nih.gov/pubmed/28316139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados